Tomson Beijian achieved revenue of 2,646 billion yuan in the first quarter, and the first ESG report was released to increase long-term development

GUANGZHOU, April 25, 2024/PRNewswire/ -- On the evening of April 25, Tomson Beijian (300146.SZ) released its report for the first quarter of 2024. Compared to the same period last year, the consumer market's high demand for products related to improving immunity declined in the first quarter of this year. Under the influence of the high base for the same period last year, Tomson Beijian's performance in the first quarter of this year rebounded. Revenue was 2,646 billion yuan, and net profit attributable to shareholders of listed companies was 727 million yuan. At the investor exchange meeting on April 11, Tomson Beijian Chairman Leung Yun-chao admitted that the industry challenges faced this year were not small. The company's views on this year's

PR NewswireApr 25 08:18 ET

Tomson Beijian (300146.SZ): Net profit of 727 million yuan in the first quarter decreased 29.43% year over year

Gelonghui, April 25 | Tomson Beijian (300146.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 2,646 billion yuan, down 14.87% year on year; net profit attributable to shareholders of listed companies was 727 million yuan, down 29.43% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 709 million yuan, down 28.67% year on year; basic earnings per share were 0.43 yuan.

Gelonghui FinanceApr 25 07:39 ET

Insiders Were the Key Beneficiaries as Byhealth Co., Ltd's (SZSE:300146) Market Cap Rises to CN¥28b

Key Insights Insiders appear to have a vested interest in Byhealth's growth, as seen by their sizeable ownership 50% of the business is held by the top 8 shareholders 14% of Byhealth is held by I

Simply Wall StApr 17 22:38 ET

Tomson Beijian (300146.SZ): Currently, the overseas business is still relatively small

Gelonghui, April 16 | Tomson Beijian (300146.SZ) said on the investor interactive platform that the company adheres to the omni-channel single focus strategy for multiple brands and categories, and will establish a network-wide digital media center and digital platform for members through the establishment of a group digital marketing center to strengthen the Group's overall e-commerce strategy and enable high-quality omnichannel growth. The company implements a “going global” strategy, continues to explore the core market in Southeast Asia, and lays out traditional pharmacy channels, cross-border and local e-commerce channels in many countries. Currently, the volume of overseas business is still relatively small.

Gelonghui FinanceApr 15 19:45 ET

Tomson Beijian (300146.SZ) plans to pay 9 yuan for 10 shares to be deducted from interest on April 22

Tomson Beijian (300146.SZ) announced that the company's 2023 equity distribution: it is intended to distribute 9 for every 10 shares...

Zhitong FinanceApr 15 08:51 ET

Tomson Beijian (300146.SZ): Probiotics are still the company's focus category this year

Gelonghui, April 3 | Tomson Beijian (300146.SZ) said during a survey from institutional investors that the company continues to be optimistic about the probiotic category circuit and the development of the Lifespace brand, and probiotics are still the company's focus category this year.

Gelonghui FinanceApr 2 19:59 ET